Allysta is a biopharmaceutical company that researches and develops peptide therapeutics for the treatment of nonalcoholic steatohepatitis. Allysta was founded in 2014. Allysta's headquarters is located in San Mateo, California, USA 94402.
Allysta's ... Allysta's CEO, Henry Hsu, currently has an approval
rating of 90%. Allysta's primary competitors are Madrigal, Metacrine & 89bio.
There have been no acquisitions found related to Allysta
Recent investment data cannot be found related to Allysta